Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: pgo-neil who wrote (10112)	2/23/2009 1:05:09 PM
From: Arthur Radley	Respond to of 10345

Graham, I really don't know anything about this guy, maybe he is trying to become the new Carl Ichan. My problem is that I have no faith in ELAN management. I think their efforts to hype the trial results for the WYE drug were extremely over the board, resulting in Wall Street/Bankers steering clear of the company. IMO, they are looking at doing funding for pharma, but why do anything with Elan at this time. Look at the Roche funding of just a few days ago......deals are being made in the industry, but not with companies that are facing the obstacles that Elan has coming in the near future. At some point, after assets are stripped away, and Elan gets down to a core operating model maybe Elan will have a true value placed on the company. But then the value might be less than what the stock is trading for today. Until some issues are removed from this stock, I think its dead money at this time. IMO!